These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 1889043)

  • 1. Diversity and origin of rheumatologic autoantibodies.
    Fritzler MJ; Salazar M
    Clin Microbiol Rev; 1991 Jul; 4(3):256-69. PubMed ID: 1889043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases.
    Routsias JG; Tzioufas AG; Moutsopoulos HM
    Clin Chim Acta; 2004 Feb; 340(1-2):1-25. PubMed ID: 14734193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of autoantibodies in systemic rheumatic diseases.
    Fritzler MJ
    Mol Biol Rep; 1996; 23(3-4):133-45. PubMed ID: 9112221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody testing: procedures and significance in systemic rheumatic diseases.
    Fritzler MJ
    Methods Achiev Exp Pathol; 1986; 12():224-60. PubMed ID: 3083214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases.
    Skriner K; Hueber W; Süleymanoglu E; Höfler E; Krenn V; Smolen J; Steiner G
    Arthritis Rheum; 2008 Feb; 58(2):511-20. PubMed ID: 18240226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases.
    van Venrooij WJ; Charles P; Maini RN
    J Immunol Methods; 1991 Jul; 140(2):181-9. PubMed ID: 1906075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral autoimmunity in systemic rheumatic disease. A review.
    Bernstein RM
    J R Coll Physicians Lond; 1990 Jan; 24(1):18-25. PubMed ID: 2407838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic diseases.
    Itoh Y; Reichlin M
    Arthritis Rheum; 1992 Jan; 35(1):73-82. PubMed ID: 1531015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrogolgin--a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infections.
    Seelig HP; Schranz P; Schröter H; Wiemann C; Renz M
    J Autoimmun; 1994 Feb; 7(1):67-91. PubMed ID: 8198703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.
    Mimori T; Suganuma K; Tanami Y; Nojima T; Matsumura M; Fujii T; Yoshizawa T; Suzuki K; Akizuki M
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7267-71. PubMed ID: 7638179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
    Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies in the diagnosis of systemic rheumatic diseases.
    von Mühlen CA; Tan EM
    Semin Arthritis Rheum; 1995 Apr; 24(5):323-58. PubMed ID: 7604300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases.
    Fritzler MJ; von Muhlen CA; Toffoli SM; Staub HL; Laxer RM
    J Rheumatol; 1995 Mar; 22(3):521-4. PubMed ID: 7783073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunogens, autoantigens, autoantibodies and autoimmune diseases: one-to-one or many-to-many relationships?
    Billings PB
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):67-79. PubMed ID: 2441720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in systemic sclerosis.
    Mehra S; Walker J; Patterson K; Fritzler MJ
    Autoimmun Rev; 2013 Jan; 12(3):340-54. PubMed ID: 22743034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1.
    Mahler M; Mierau R; Schlumberger W; Blüthner M
    J Mol Med (Berl); 2001 Dec; 79(12):722-31. PubMed ID: 11862315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoantibodies against histones and actin determined by western blotting in patients with rheumatic diseases].
    Raska I; Petrasovicová V; Jarník M; Cebecauer L; Lukacovicová L; Lejnar J; Viklický V; Mácha J; Jíra M; Trnavský K
    Cas Lek Cesk; 1990 Nov; 129(47):1495-500. PubMed ID: 2257596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.